Induction of IL-13 production and upregulation of gene expression of protease activated receptors in P815 cells by IL-6.
Interleukin (IL)-6 is a multifunctional cytokine which has been showed to induce up-regulated expression of Fc epsilon RI receptor and histamine production in mast cells. However, little is known of its effects on Th2 cytokine secretion and protease activated receptor (PAR) expression in mast cells. In the present study, we examined potential influence of IL-6 on IL-13, IL-4 and IL-10 release from P815 cells and PAR expression on P815 cells by using flow cytometry analysis, quantitative real-time PCR, ELISA and cellular activation of signaling ELISA (CASE) techniques. The results showed that IL-6 induced up to 1.8-fold increase in IL-13, but not IL-4 or IL-10 release from P815 cells, and FSLLRY-NH(2) did not affect IL-6 induced IL-13 release. Tryptase elicited 2.0-fold increase in IL-13 release from P815 cells, which can be inhibited by IL-6. IL-6 elicited the up-regulated expression of PAR-1, PAR-2, PAR-3 and PAR-4 mRNAs, but had little effects on expression of PAR proteins. U0126, PD98059 and LY204002 abolished IL-6 induced IL-13 release when they were preincubated with P815 cells, indicating ERK and Akt cell signaling pathways may be involved in the event. In conclusion, IL-6 can stimulate IL-13 release from mast cells through an ERK and Akt cell signaling pathway dependent, but PAR independent mechanism.
Zhang
Huiyun
H
Department of Pathophysiology, Hainan Medical College, Haikou, Hainan, China. zhanghuiyun2003@126.com
Lin
Liyan
L
Yang
Haiwei
H
Zhang
Zhongfang
Z
Yang
Xiaoyu
X
Zhang
Lianxia
L
He
Shaoheng
S
D000818:Animals; D002867:Chromones / Q000494:pharmacology; D048049:Extracellular Signal-Regulated MAP Kinases / Q000037:antagonists & inhibitors; D006801:Humans; D018793:Interleukin-13 / Q000096:biosynthesis* / Q000378:metabolism; D015850:Interleukin-6 / Q000494:pharmacology*; D008407:Mast Cells / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism*; D051379:Mice; D009025:Morpholines / Q000494:pharmacology; D010766:Phosphorylation / Q000187:drug effects; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D044462:Receptors, Proteinase-Activated / Q000235:genetics* / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000187:drug effects; D018418:Th2 Cells / Q000187:drug effects / Q000378:metabolism; D053802:Tryptases / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects*
D002867:Chromones; D018793:Interleukin-13; D015850:Interleukin-6; D009025:Morpholines; D047428:Protein Kinase Inhibitors; D044462:Receptors, Proteinase-Activated; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; D048049:Extracellular Signal-Regulated MAP Kinases; D053802:Tryptases